Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis

Oral Microbiology and Immunology

Volumn 20, Issue 5, 2005, Pages 296-302

  Ford, P J ^a   Gemmell, E ^a   Hamlet, S M ^a   Hasan, A ^a   Walker, P J ^a   West, M J ^a   Cullinan, M P ^a   Seymour, G J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antibody responses; Atherosclerosis; Heat shock proteins; Molecular mimicry; Periodontal immunology

Indexed keywords

CHAPERONIN; HEAT SHOCK PROTEIN 60;

ARTICLE; ATHEROMA; ATHEROSCLEROSIS; BACTERIUM IDENTIFICATION; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; FUSOBACTERIUM NUCLEATUM; HAEMOPHILUS INFLUENZAE TYPE A; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PREVALENCE; TANNERELLA FORSYTHENSIS;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ARTERIOSCLEROSIS; BACTEROIDES; CAROTID ARTERY DISEASES; CHAPERONIN 60; CHLAMYDOPHILA PNEUMONIAE; CROSS REACTIONS; ENDOTHELIUM, VASCULAR; FUSOBACTERIUM NUCLEATUM; GROEL PROTEIN; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; PERIODONTAL POCKET; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; SMOKING;

EID: 23944483674     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2005.00230.x     Document Type: Article

References (38)

1. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996: 11: 266-273.
2. Bird PS, Seymour GJ. Production of monoclonal antibodies that recognise specific and cross-reactive antigens of Fusobacterium nucleatum. Infect Immun 1987: 55: 771-777.
3. Buhlin K, Gustafsson A, Pockley AG, Frostegard J, Klinge B. Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 2003: 24: 2099-2107.
4. Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 2003: 74: 1007-1016.
5. DeStefano F, Anda RF, Kahn S, Williamson DF, Russell CM. Dental disease and the risk of coronary heart disease and mortality. BMJ 1993: 306: 688-691.
6. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR, Papapanou PN, et al. Relationship between periodontal disease, tooth loss, and carotid artery plaque. The oral infections and vascular disease epidemiology study (INVEST). Stroke 2003: 34: 2120-2125.
7. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 2002: 90: 2-4.
8. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, et al. Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection? Stroke 2000: 31: 2127-2133.
9. Furuichi Y, Shimotsu A, Ito H, Namariyama Y, Yotsumoto Y, Hino Y, et al. Associations of periodontal status with general health conditions and serum antibody titres for Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. J Periodontol 2003: 74: 1491-1497.
10. Gemmell E, Bird P, Carter CL, Drysdale KE, Seymour GJ. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model. Clin Exp Immunol 2002: 128: 238-244.
11. Gemmell E, Winning TA, Grieco DA, Bird P, Seymour GJ. The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice. J Periodontol 2000: 71: 1130-1138.
12. Grau A, Buggle F, Ziegler C, Schwarz W, Meuser J, Tasman A-J, et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 1997: 28: 1724-1729.
13. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000: 71: 1554-1560.
14. Hung H-C, Willet W, Merchant A, Rosner BA, Ascherio A, Joshipura KJ. Oral health and peripheral arterial disease. Circulation 2003: 107: 1152-1157.
15. Kurihara N, Inoue Y, Iwai T, Umeda M, Huang Y, Ishikawa I. Detection and localization of periodontopathic bacteria in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2004: 28: 553-558.
16. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003: 23: 1405-1411.
17. Lamster IB, Kaluszhner-Shapira I, Herrera-Abreu M, Sinha R, Grbic JT. Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal disease diagnosis. J Clin Periodontol 1998: 25: 510-516.
18. Li L, Messas E, Batista EL, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002: 105: 861-867.
19. Lindquist S, Craig EA. The heat-shock proteins. Ann Rev Genet 1988: 22: 631-677.
20. Mayr M, Metzler B, Kiechl S, Willeit J, Schert G, Xu Q, et al. Endothelial cytotoxicity mediated by serum antibodies to heat-shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat-shock proteins as a possible link between infection and atherosclerosis. Circulation 1999: 99: 1560-1566.
21. Metzler B, Schert G, Kleindienst R, van der Zee R, Ottenhoff T, Hajeer A, et al. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler Thromb Vasc Biol 1997: 17: 536-541.
22. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of cardiovascular disease. J Am Coll Cardiol 1996: 27: 1555-1561.
23. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR, et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000: 102: 1917-1923.
24. Pasceri V, Cammarota G, Parti G, Cuoco L, Gasbarrini A, Grillo R, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998: 97: 1675-1679.
25. Paterson DL, Hall JH, Rasmussen SJ, Timms P. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology 1998: 30: 169-172.
26. Polla BS. A role for heat shock proteins in inflammation? Immunol Today 1988: 9: 134-137.
27. Prasad A, Zhu J, Halcox JPJ, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: Role of endothelial dysfunction. Circulation 2002: 106: 184-190.
28. Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 1997: 29: 308-317.
29. Schert G, Metzler B, Kleindienst R, Moschen I, Hattmannsdorfer R, Wolf H, et al. Salivary anti-hsp65 antibodies as a diagnostic marker for gingivitis and a possible link to atherosclerosis. Int Arch Allergy Immunol 1997: 114: 246-250.
30. Shi Y, Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 2002: 52: 31-39.
31. Stelzel M, Conrads G, Pankuweit S, Maisch B, Vogt S, Moosdorf R, Flores-de-Jacoby L. Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol 2002: 73: 868-870.
32. Syrjanen J, Valtonen W, Iivanainen M, Kaste M, Huttunen JK. Preceding infection as an important risk factor for ischemic brain infarction in young and middle aged patients. BMJ 1988: 296: 1156-1160.
33. Tondella ML, Talkington DF, Holloway BP, Dowell SF, Cowley K, Soriano-Gabarro M, et al. Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol 2002: 40: 575-583.
34. Valtonen VV. Role of infections in atherosclerosis. Am Heart J 1999: 138: S431-S433.
35. Wick G, Perschinka H, Xu Q. Autoimmunity and atherosclerosis. Am Heart J 1999: 138: S444-S449.
36. Yamazaki K, Ohsawa Y, Itoh H, Ueki K, Tabeta K, Oda T, et al. T-cell clonality to Porphyromonas gingivalis and human heat shock protein 60s in patients with atherosclerosis and periodontitis. Oral Microbiol Immunol 2004: 19: 160-167.
37. Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis 2000: 182: 1583-1587.
38. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000: 85: 140-146.